Korro Bio, Inc. announced that its CEO, Dr. Ram Aiyar, will present at the TD Cowen 46th Annual Health Care Conference on March 3, 2026, at 11:10 a.m. ET. The biopharmaceutical company focuses on developing genetic medicines through RNA editing for rare and common diseases. This presentation aims to highlight Korro Bio’s innovative approach and proprietary technology to investors and industry professionals.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Korro Bio, Inc. CEO Ram Aiyar to Present at TD Cowen 46th Annual Health Care Conference
Korro Bio, Inc. announced that its CEO, Dr. Ram Aiyar, will present at the TD Cowen 46th Annual Health Care Conference on March 3, 2026, at 11:10 a.m. ET. The biopharmaceutical company focuses on developing genetic medicines through RNA editing for rare and common diseases. This presentation aims to highlight Korro Bio’s innovative approach and proprietary technology to investors and industry professionals.